KSKazunari Sasaki

Kazunari Sasaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kazunari Sasaki has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma

    by Kazunari Sasaki, Masamichi Matsuda, Yu Ohkura, Yusuke Kawamura, Masafumi Inoue, Masaji Hashimoto, Kenji Ikeda, Hiromitsu Kumada, Goro Watanabe


  • Factors associated with early cancer‐related death after curative hepatectomy for solitary small hepatocellular carcinoma without macroscopic vascular invasion

    by Kazunari Sasaki, Masamichi Matsuda, Yu Ohkura, Yusuke Kawamura, Masafumi Inoue, Masaji Hashimoto, Kenji Ikeda, Hiromitsu Kumada, Goro Watanabe

    Background Unexpected early cancer‐related death (ECRD) within 2 years due to recurrence after curative hepatectomy for solitary small ( 3 cm and elevation of tumor marker level were independent predictors of ECRD. In the analysis with all variables, excessive intraoperative blood loss, poor differentiation, and microscopic vascular invasion were predictors of ECRD. In the recurrence patterns, 79% of ECRD presented as advanced (four or more lesions) or extra‐hepatic recurrence, whereas these accounted for 18% in the non‐ECRD. Conclusion Excessive blood loss during the operation and histopathological findings of microscopic vascular invasion and poor differentiation are predictive factors of cancer‐related death within 2 years of a hepatectomy for SSHCC.


  • Clinical significance of hepatectomy for primary biliary cirrhosis patients with hepatocellular carcinoma: Report of a single center case series and review of the published work

    by Kazunari Sasaki, Masamichi Matsuda, Yu Ohkura, Yusuke Kawamura, Masafumi Inoue, Yoshiyuki Suzuki, Masaji Hashimoto, Kenji Ikeda, Hiromitsu Kumada, Goro Watanabe

    Aim Hepatectomy for hepatocellular carcinoma (HCC) in patients with primary biliary cirrhosis (PBC) has seldom been reported, and the clinical significance of this procedure remains unclear, although HCC has often been observed in end‐stage PBC patients. Methods To understand the characteristics of hepatectomy on HCC in PBC patients, we examined seven cases at our institute, as well as 22 reported hepatectomy cases in the English‐language and Japanese published work. Furthermore, to assess the treatment efficacy of hepatectomy for HCC in PBC patients, we compared these patients with viral hepatitis patients who underwent hepatectomies at our institute during the same period. Results In the review of 29 cases, more than 70% of the patients were aged over 65 years, and the mean Mayo risk score was low at 5.17. The resected tumors were mainly solitary (79%), and the median maximum tumor size was 37 mm. Approximately two‐thirds of the patients met the Milan criteria. In the comparison between the PBC and viral hepatitis cases, there were no differences in the postoperative prognoses, although the tumor size was greater in the PBC cases. Conclusion Hepatectomy for HCC in selected PBC cases is a feasible and potentially curative treatment option, similar to hepatectomy for HCC in viral hepatitis patients. This procedure is particularly useful for patients with preserved liver function who are not ideal candidates for liver transplantation.


  • Minimum resection margin should be based on tumor size in hepatectomy for hepatocellular carcinoma in hepatoviral infection patients

    by Kazunari Sasaki, Masamichi Matsuda, Yu Ohkura, Yusuke Kawamura, Masaji Hashimoto, Kenji Ikeda, Hiromitsu Kumada, Goro Watanabe

    Aim: In patients with hepatoviral infection, although a wide resection margin can eradicate the microsatellite lesions around hepatocellular carcinoma (HCC), a large‐volume hepatectomy may diminish remaining liver function and become an obstacle for treating recurrent HCC. The optimal width of the resection margin for these patients is still controversial. This study was conducted to investigate the optimal resection margin in hepatectomy for hepatoviral infection patients.Methods: We retrospectively investigated the influences of the resection margin status on recurrence patterns and long‐term prognosis in a group of 311 HCC patients with hepatoviral infection who had a solitary HCC without perioperative anti‐HCC treatment.Results: The resection margin status did not statistically influence the postoperative recurrence‐free and overall survival rates (3‐year recurrence‐free survival of 61.0% vs 55.1%, P = 0.33; 5‐year overall survival of 74.9% vs 81.5%, P = 0.77 in without a margin vs with a margin, respectively), although resection without a margin increased the local recurrence with marginal significance (P = 0.055). Regarding the width of the resection margin, in 30‐mm or smaller HCC, resection margin did not significantly improve the prognosis among hepatoviral infection patients. However, for tumors larger than 30 mm, a resection margin wider than 3 mm showed significant impacts on the prevention of recurrence in spite of the influence of multicentric carcinogenesis.Conclusion: The resection margin used for eradication of microsatellite lesions showed differences that were dependent on tumor size in hepatoviral infection patients. Resection margin should be based on not only background liver function but also tumor characteristics.